Broadfin Capital Llc increased Angiodynamics Inc (ANGO) stake by 5.21% reported in 2017Q3 SEC filing. Broadfin Capital Llc acquired 87,688 shares as Angiodynamics Inc (ANGO)’s stock declined 6.23%. The Broadfin Capital Llc holds 1.77M shares with $30.27 million value, up from 1.68 million last quarter. Angiodynamics Inc now has $613.15M valuation. The stock increased 1.64% or $0.27 during the last trading session, reaching $16.7. About 191,771 shares traded. AngioDynamics, Inc. (NASDAQ:ANGO) has risen 31.47% since January 19, 2017 and is uptrending. It has outperformed by 14.77% the S&P500.
Research Frontiers Incorporated (NASDAQ:REFR) had a decrease of 6.21% in short interest. REFR’s SI was 763,200 shares in January as released by FINRA. Its down 6.21% from 813,700 shares previously. With 40,900 avg volume, 19 days are for Research Frontiers Incorporated (NASDAQ:REFR)’s short sellers to cover REFR’s short positions. The SI to Research Frontiers Incorporated’s float is 4.42%. The stock decreased 2.83% or $0.03 during the last trading session, reaching $1.03. About 4,878 shares traded. Research Frontiers Incorporated (NASDAQ:REFR) has declined 72.08% since January 19, 2017 and is downtrending. It has underperformed by 88.78% the S&P500.
Investors sentiment decreased to 1.17 in Q3 2017. Its down 1.32, from 2.49 in 2017Q2. It dropped, as 13 investors sold ANGO shares while 52 reduced holdings. 24 funds opened positions while 52 raised stakes. 33.36 million shares or 0.00% more from 33.36 million shares in 2017Q2 were reported. Arizona State Retirement invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). Thrivent For Lutherans has invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). State Street Corp reported 0% stake. Millennium Ltd Llc reported 0.01% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO). Brinker Cap has 0.01% invested in AngioDynamics, Inc. (NASDAQ:ANGO). Aqr Cap Mngmt Lc has invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). Jacobs Levy Equity invested 0.04% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO). Pub Sector Pension Inv Board holds 21,850 shares. Meeder Asset Mngmt Inc holds 0% in AngioDynamics, Inc. (NASDAQ:ANGO) or 426 shares. Bank Of Montreal Can has invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). Prudential Financial Inc reported 315,051 shares or 0.01% of all its holdings. Trexquant Limited Partnership owns 0.04% invested in AngioDynamics, Inc. (NASDAQ:ANGO) for 10,220 shares. 5,000 are held by Barclays Public Ltd Com. Legal & General Grp Public Limited Co accumulated 0% or 65,557 shares. Lapides Asset Management Ltd has invested 1.66% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO).
Among 8 analysts covering AngioDynamics (NASDAQ:ANGO), 1 have Buy rating, 0 Sell and 7 Hold. Therefore 13% are positive. AngioDynamics had 20 analyst reports since July 24, 2015 according to SRatingsIntel. Canaccord Genuity maintained the shares of ANGO in report on Wednesday, May 31 with “Hold” rating. As per Sunday, October 8, the company rating was maintained by Canaccord Genuity. Canaccord Genuity maintained it with “Buy” rating and $14.5 target in Friday, January 8 report. The company was maintained on Thursday, January 4 by Canaccord Genuity. The firm earned “Sell” rating on Monday, August 31 by Zacks. The firm earned “Hold” rating on Thursday, September 28 by KeyBanc Capital Markets. The firm has “Equal Weight” rating given on Wednesday, February 8 by Barclays Capital. The rating was maintained by Canaccord Genuity on Sunday, August 6 with “Hold”. The firm has “Hold” rating by Canaccord Genuity given on Monday, July 10. As per Friday, January 5, the company rating was downgraded by Craig Hallum.
Research Frontiers Incorporated develops and markets technology and devices to control the flow of light in the United States. The company has market cap of $24.77 million. The firm develops and licenses suspended particle device light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, lamination services, and electronics to power end-products incorporating the film, as well as the end-products, such as windows, skylights, and sunroofs. It currently has negative earnings. The Company’s SPD-Smart light-control technology is used in various product applications, including windows, sunshades, skylights, and interior partitions for homes and buildings; automotive windows, sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels, and navigation systems; aircraft windows; eyewear products; and flat panel displays for electronic products.
Investors sentiment increased to 1.2 in 2017 Q3. Its up 0.06, from 1.14 in 2017Q2. It increased, as 3 investors sold Research Frontiers Incorporated shares while 7 reduced holdings. 7 funds opened positions while 5 raised stakes. 4.22 million shares or 0.40% more from 4.20 million shares in 2017Q2 were reported. State Street stated it has 10,720 shares. 700 are owned by Bank Of Montreal Can. Northwestern Mutual Wealth reported 93 shares. Northern Corporation has 43,389 shares for 0% of their portfolio. United Capital Advisers Ltd stated it has 29,077 shares or 0% of all its holdings. Blackrock Inc has 0% invested in Research Frontiers Incorporated (NASDAQ:REFR). Outfitter Advsr Ltd accumulated 0.01% or 24,000 shares. Price T Rowe Md holds 0% of its portfolio in Research Frontiers Incorporated (NASDAQ:REFR) for 31,600 shares. Morgan Stanley invested in 10,299 shares or 0% of the stock. Vanguard Grp has 0% invested in Research Frontiers Incorporated (NASDAQ:REFR). Wells Fargo Mn, a California-based fund reported 19,501 shares. 62,841 are owned by California Pub Employees Retirement Systems. Financial Bank Of New York Mellon Corporation, a New York-based fund reported 24,304 shares. Royal State Bank Of Canada holds 0% in Research Frontiers Incorporated (NASDAQ:REFR) or 17 shares. First Allied Advisory Serv reported 0% in Research Frontiers Incorporated (NASDAQ:REFR).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.